Current Drug Metabolism

Current Drug Metabolism is published by Bentham Science Publishers B.V. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmacogenetics and Drug Metabolism, Computational Drug Discovery Methods and Drug Transport and Resistance Mechanisms, together about 37.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. The journal serves as an international forum for the publication of full-length/mini review, research articles and guest edited issues in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the most important developments. The journal covers the following general topic areas: pharmaceutics, pharmacokinetics, toxicology, and most importantly drug metabolism. More specifically, in vitro and in vivo drug metabolism of phase I and phase II enzymes or metabolic pathways; drug-drug interactions and enzyme kinetics; pharmacokinetics, pharmacokinetic-pharmacodynamic modeling, and toxicokinetics; interspecies differences in metabolism or pharmacokinetics, species scaling and extrapolations; drug transporters; target organ toxicity and interindividual variability in drug exposure-response; extrahepatic metabolism; bioactivation, reactive metabolites, and developments for the identification of drug metabolites. Preclinical and clinical reviews describing the drug metabolism and pharmacokinetics of marketed drugs or drug classes.

Source: LetPub

Research area (LetPub): Biochemistry & Molecular Biology

CAS Journal Ranking

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

2.31LetPub · 2026-09-13

CiteScore 2026-06

3.9LetPub · 2026-09-13

SJR 2026-06

0.49LetPub · 2026-09-13

SNIP 2026-06

0.49LetPub · 2026-09-13

h-index

97LetPub · 2026-09-13

h-index

140OpenAlex · 2026-10-01

i10-index

1,388OpenAlex · 2026-10-01

2-year mean citedness

2.16OpenAlex · 2026-10-01

Self-citation rate

4.3%LetPub · 2026-09-13

Share of gold OA articles

6.04%LetPub · 2026-09-13

Volume

Articles per year

56LetPub · 2026-09-13

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

4–8 weeksLetPub · 2026-09-13

Average acceptance (community reports)

ModerateLetPub · 2026-09-13

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Publisher

Bentham Science Publishers B.V.

Country or region

NETHERLANDS

Language

English

Frequency

Quarterly

Founded

2000

ISSN

1389-2002

Electronic ISSN

1875-5453

Official links

• Journal homepage ↗LetPub
• Submission system ↗LetPub